McKesson Corporation $MCK Stock Bought by Rakuten Investment Management Inc.

Rakuten Investment Management Inc. lifted its position in McKesson Corporation (NYSE:MCK) by 5.9% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 20,958 shares of the company’s stock after buying an additional 1,166 shares during the period. Rakuten Investment Management Inc.’s holdings in McKesson were worth $18,125,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of the business. Secure Asset Management LLC boosted its holdings in shares of McKesson by 484.8% in the 2nd quarter. Secure Asset Management LLC now owns 2,123 shares of the company’s stock valued at $1,604,000 after buying an additional 1,760 shares in the last quarter. Royal London Asset Management Ltd. lifted its stake in McKesson by 1.1% during the 2nd quarter. Royal London Asset Management Ltd. now owns 112,241 shares of the company’s stock valued at $84,809,000 after acquiring an additional 1,216 shares during the period. BayBridge Capital Group LLC grew its position in McKesson by 268.0% during the 2nd quarter. BayBridge Capital Group LLC now owns 1,943 shares of the company’s stock worth $1,468,000 after purchasing an additional 1,415 shares during the period. Benchmark Investment Advisors LLC purchased a new position in McKesson during the second quarter valued at approximately $441,000. Finally, One Wealth Advisors LLC acquired a new position in shares of McKesson in the 2nd quarter valued at $1,494,000. Institutional investors own 85.07% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on MCK. Citigroup boosted their price target on shares of McKesson from $945.00 to $1,000.00 and gave the stock a “buy” rating in a report on Friday, July 24th. TD Cowen raised their price objective on McKesson from $989.00 to $1,006.00 and gave the company a “buy” rating in a report on Thursday, August 6th. Bank of America upped their target price on shares of McKesson from $950.00 to $1,050.00 in a report on Thursday, August 6th. Weiss Ratings raised McKesson from a “buy (b-)” rating to a “buy (b)” rating in a report on Friday, September 4th. Finally, Robert W. Baird set a $1,015.00 price target on McKesson in a report on Thursday, August 6th. Fifteen research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $997.12.

Insider Buying and Selling

In other news, Director Bradley E. Lerman sold 301 shares of McKesson stock in a transaction on Monday, August 10th. The shares were sold at an average price of $892.33, for a total transaction of $268,591.33. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Francisco Fraga sold 800 shares of the stock in a transaction dated Thursday, October 15th. The shares were sold at an average price of $995.80, for a total value of $796,640.00. Following the completion of the transaction, the executive vice president owned 5,423 shares in the company, valued at approximately $5,400,223.40. The trade was a 12.86% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 1,212 shares of company stock valued at $1,164,182 in the last three months. 0.06% of the stock is owned by corporate insiders.

McKesson News Roundup

Here are the key news stories impacting McKesson this week:

• Positive Sentiment: McKesson earned $11.68 per share, above the roughly $10.72 consensus, and revenue was $110.96 billion versus estimates of $109.90 billion. EPS rose from $9.86 a year earlier, while revenue increased 7.5% year over year—evidence of stronger-than-expected quarterly performance. McKesson quarterly earnings results
• Positive Sentiment: Shares also benefited from positive sentiment around peer Cencora’s earnings, according to coverage of McKesson’s move. McKesson gains after rival Cencora files earnings
• Neutral Sentiment: The board affirmed McKesson’s regular quarterly dividend of $0.94 per share, payable January 4, 2027. The reaffirmation supports continuity in shareholder returns but does not signal a dividend increase. Why McKesson is back in the spotlight
• Neutral Sentiment: Before the report, analysts flagged branded-drug pricing pressure as a potential counterweight to prescription-volume, specialty-distribution and oncology growth. The provided results coverage does not clarify how those pressures may affect future performance. Will pharma and specialty demand offset pricing headwinds?

McKesson Stock Performance

Shares of MCK stock opened at $1,069.31 on Thursday. McKesson Corporation has a one year low of $723.68 and a one year high of $1,073.95. The firm’s 50 day moving average price is $931.17 and its 200-day moving average price is $865.74. The firm has a market cap of $124.67 billion, a P/E ratio of 28.61, a P/E/G ratio of 1.99 and a beta of 0.27.

McKesson (NYSE:MCK) last announced its earnings results on Wednesday, November 4th. The company reported $11.68 EPS for the quarter, beating analysts’ consensus estimates of $10.72 by $0.96. McKesson had a negative return on equity of 253.21% and a net margin of 1.12%. The company had revenue of $110.96 billion during the quarter, compared to analysts’ expectations of $109.90 billion. During the same period last year, the business posted $9.86 EPS. McKesson’s revenue for the quarter was up 7.5% on a year-over-year basis. As a group, research analysts predict that McKesson Corporation will post 44.71 EPS for the current fiscal year.

McKesson Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, January 4th. Investors of record on Tuesday, December 1st will be issued a $0.94 dividend. The ex-dividend date is Tuesday, December 1st. This represents a $3.76 dividend on an annualized basis and a yield of 0.4%. McKesson’s dividend payout ratio (DPR) is 10.06%.

About McKesson

McKesson Corporation is a healthcare services and information technology company that distributes pharmaceuticals and medical products to pharmacies, hospitals, health systems, physicians and other healthcare providers. The company also provides technology, data and business solutions designed to support prescription management, pharmacy operations and patient care.

McKesson’s principal activities include pharmaceutical distribution, medical-surgical supply distribution, specialty pharmaceutical services and oncology care support.